Literature DB >> 9234775

Activation of the interleukin-1beta precursor by Treponema denticola: a potential role in chronic inflammatory periodontal diseases.

A Beauséjour1, N Deslauriers, D Grenier.   

Abstract

There are several indications suggesting that interleukin-1beta (IL-1beta) may play an important role in inflammatory periodontal diseases. We hypothesized that periodontal sites would represent a unique combination of both cellular sources of IL-1beta precursor (pro-IL-1beta) and microbial proteases and proposed that Treponema denticola, a suspected periodontal pathogen, would play a critical role in the inflammatory nature of adult chronic periodontitis by activating pro-IL-1beta. The aim of this study was thus to demonstrate the proteolytic cleavage and activation of the inactive precursor pro-IL-1beta by T. denticola. After incubation of bacterial cells with recombinant pro-IL-1beta, proteolytic cleavage was monitored by Western immunoblotting, and the biological activity of the digestion products was tested in a bioassay. We report here that T. denticola can cleave pro-IL-1beta to yield two fragments with molecular masses of 18 and 19 kDa. Cleavage products showed a dose-dependent biological activity in the thymocyte proliferation bioassay, and this activity was inhibited by anti-IL-1beta neutralizing antibodies. These results suggest that T. denticola may have a proinflammatory role in periodontal diseases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9234775      PMCID: PMC175452          DOI: 10.1128/iai.65.8.3199-3202.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Degradation of host protease inhibitors and activation of plasminogen by proteolytic enzymes from Porphyromonas gingivalis and Treponema denticola.

Authors:  Daniel Grenier
Journal:  Microbiology (Reading)       Date:  1996-04       Impact factor: 2.777

Review 2.  Microbial etiological agents of destructive periodontal diseases.

Authors:  A D Haffajee; S S Socransky
Journal:  Periodontol 2000       Date:  1994-06       Impact factor: 7.589

3.  Adult periodontitis: an ecological perspective of mixed infections.

Authors:  D Grenier; D Mayrand
Journal:  Trends Microbiol       Date:  1995-04       Impact factor: 17.079

4.  Characterization of fibrinolytic activities of Treponema denticola.

Authors:  G Rosen; R Naor; S Kutner; M N Sela
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Interleukin-1 beta converting enzyme.

Authors:  N A Thornberry
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

Review 6.  The peptidolytic capacity of the spirochete system.

Authors:  K K Mäkinen; P L Mäkinen
Journal:  Med Microbiol Immunol       Date:  1996-05       Impact factor: 3.402

7.  Cytopathic effects of Treponema denticola chymotrypsin-like proteinase on migrating and stratified epithelial cells.

Authors:  V J Uitto; Y M Pan; W K Leung; H Larjava; R P Ellen; B B Finlay; B C McBride
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Proline iminopeptidase from the outer cell envelope of the human oral spirochete Treponema denticola ATCC 35405.

Authors:  K K Mäkinen; C Y Chen; P L Mäkinen
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 9.  The biological properties of interleukin-1.

Authors:  C A Dinarello
Journal:  Eur Cytokine Netw       Date:  1994 Nov-Dec       Impact factor: 2.737

10.  Crevicular interleukin-1 beta in moderate and severe periodontitis patients and the effect of phase I periodontal treatment.

Authors:  L T Hou; C M Liu; E F Rossomando
Journal:  J Clin Periodontol       Date:  1995-02       Impact factor: 8.728

View more
  10 in total

Review 1.  Virulence factors of the oral spirochete Treponema denticola.

Authors:  S G Dashper; C A Seers; K H Tan; E C Reynolds
Journal:  J Dent Res       Date:  2010-10-12       Impact factor: 6.116

2.  Proteolytic activation of the interleukin-1beta precursor by Candida albicans.

Authors:  A Beauséjour; D Grenier; J P Goulet; N Deslauriers
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Activation of murine macrophages by lipoprotein and lipooligosaccharide of Treponema denticola.

Authors:  G Rosen; M N Sela; R Naor; A Halabi; V Barak; L Shapira
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Quantitative gene expression profiling implicates genes for susceptibility and resistance to alveolar bone loss.

Authors:  G T Hart; D J Shaffer; S Akilesh; A C Brown; L Moran; D C Roopenian; P J Baker
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

5.  Treponema denticola activates mitogen-activated protein kinase signal pathways through Toll-like receptor 2.

Authors:  John Ruby; Kunal Rehani; Michael Martin
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

6.  The Treponema denticola surface protease dentilisin degrades interleukin-1 beta (IL-1 beta), IL-6, and tumor necrosis factor alpha.

Authors:  Meguru Miyamoto; Kazuyuki Ishihara; Katsuji Okuda
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

7.  Treponema denticola is resistant to human beta-defensins.

Authors:  Catherine A Brissette; Sheila A Lukehart
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

8.  Filament formation associated with spirochetal infection: a comparative approach to Morgellons disease.

Authors:  Marianne J Middelveen; Raphael B Stricker
Journal:  Clin Cosmet Investig Dermatol       Date:  2011-11-14

9.  Interleukin-33 is activated by allergen- and necrosis-associated proteolytic activities to regulate its alarmin activity during epithelial damage.

Authors:  Ian C Scott; Jayesh B Majithiya; Caroline Sanden; Peter Thornton; Philip N Sanders; Tom Moore; Molly Guscott; Dominic J Corkill; Jonas S Erjefält; E Suzanne Cohen
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

Review 10.  Inflammasome/IL-1β Responses to Streptococcal Pathogens.

Authors:  Christopher N LaRock; Victor Nizet
Journal:  Front Immunol       Date:  2015-10-08       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.